Emergent BioSolutions Q2 2026 Revenue Up 66%, Net Loss
August 05, 2026
1 min read
8 views
cybersecurity
news
newsapi
Emergent BioSolutions reported Q2 2026 revenues of $234.3 million, up 66% year-over-year, but net loss widened to $180.2 million, a 1,402% increase.
Was this article helpful?
0 found this helpful